4170 Competitors

Stocks . Taiwan . 
Stock . 4170
4170 Stock  TWD 15.60  0.65  4.35%   
4170 competes with TaiwanJ Pharmaceuticals, Pharmigene, BioLASCO Taiwan, Bioray Biotech, and Eusol Biotech; as well as few others. The company operates under Healthcare sector and is part of Diagnostics & Research industry. Analyzing 4170 competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of 4170 to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out 4170 Correlation with its peers.

4170 vs Original BioMedicals Correlation

Average diversification

The correlation between 4170 and 6483 is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding 4170 and 6483 in the same portfolio, assuming nothing else is changed.

Moving against 4170 Stock

  0.311235 Shin Tai IndustryPairCorr
Hype
Prediction
LowEstimatedHigh
12.8315.6018.37
Details
Intrinsic
Valuation
LowRealHigh
9.8612.6317.16
Details
Naive
Forecast
LowNextHigh
13.0915.8618.63
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
13.0114.1515.30
Details

4170 Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between 4170 and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of 4170 and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of 4170 does not affect the price movement of the other competitor.

High positive correlations

4192
+ 0.66
6549
7561
+ 0.66
1781
6483
+ 0.66
6652
6652
+ 0.64
6549
7607
+ 0.62
7595
6483
+ 0.61
4115
  

High negative correlations

6483
- 0.62
7561
6483
- 0.59
1781
7595
- 0.55
1781
7561
- 0.53
7595
4115
- 0.43
7561
6652
- 0.42
7561

Risk-Adjusted Indicators

There is a big difference between 4170 Stock performing well and 4170 Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze 4170's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
6549  1.23  0.19  0.05 (1.27) 1.18 
(1.81)
 4.07 
(2.74)
 7.70 
1781  0.75 (0.08) 0.00 (0.38) 0.00 
 0.00 
 0.91 
(1.33)
 10.60 
7595  1.44 (0.26) 0.00 (0.46) 0.00 
 0.00 
 3.43 
(3.82)
 7.09 
6662  0.93 (0.10) 0.00  1.53  0.00 
 0.00 
 2.14 
(1.75)
 5.46 
7561  2.53  0.67  0.18 (1.88) 2.12 
(3.38)
 6.97 
(4.31)
 14.96 
6652  1.98 (0.01) 0.00  0.22  0.00 
 0.00 
 5.08 
(4.69)
 11.56 
7607  1.72 (0.14) 0.00  2.15  0.00 
 0.00 
 4.63 
(4.65)
 13.34 
4115  1.33  0.04 (0.02) 0.31  1.49 
(2.30)
 3.95 
(3.57)
 8.68 
4192  1.28 (0.19) 0.00  0.59  0.00 
 0.00 
 2.30 
(4.15)
 10.16 
6483  2.30  0.05 (0.01) 2.65  2.53 
(2.91)
 6.29 
(4.15)
 20.34 

4170 Competitive Analysis

The better you understand 4170 competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, 4170's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across 4170's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
4170 6549 1781 7595 6662 7561 6652 7607 4115 4192
 4.35 
 15.60 
4170
 5.06 
 8.10 
TaiwanJ
 0.82 
 12.05 
Health
 3.82 
 9.56 
Pharmigene
 0.49 
 30.30 
BioLASCO
 4.00 
 26.00 
Bioray
 0.68 
 5.80 
Eusol
 2.17 
 18.80 
7607
 3.95 
 8.42 
Sunder
 1.64 
 24.00 
SynCore
Market Volatility
(90 Days Market Risk)
Somewhat reliable
Somewhat reliable
Not too volatile
Not too volatile
Very steady
Not too volatile
Slightly risky
Not too volatile
Somewhat reliable
Very steady
Market Performance
(90 Days Performance)
Mild
Fair
Weakest
Weakest
Weakest
Good
Weakest
Weakest
Weak
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Moderate
Moderate
Fair
Low
Low
Low
High
Unknown
Unknown
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Fairly Valued
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Cautious Hold
Hold
Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
4.47
14.77
N/A
14.16
7.75
3.02
6.16
N/A
N/A
5.04
Net Asset
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
824.44 M
Profit Margin
-14.7
-237.97
N/A
-11.06
19.91
-0.04
N/A
N/A
N/A
N/A
EBITDA
(55.28 M)
10.42 M
N/A
(8.73 M)
69.58 M
9.36 M
(89.6 M)
N/A
N/A
(404.13 M)
Operating Margin
-32.96
-16.9
N/A
-13.68
23.75
-0.14
N/A
N/A
N/A
-13.97
Current Valuation
674.16 M
641.12 M
N/A
717.33 M
595.07 M
725.35 M
2.67 B
N/A
N/A
2.86 B
Price To Book
2.24
4.23
N/A
2.49
1.68
2.04
6.21
N/A
N/A
9.34
Beta
0.41
0.27
N/A
N/A
0.44
N/A
0.91
N/A
N/A
1.14
Number Of Employees
10
16
7
N/A
79
79
6
N/A
N/A
65
Shares Outstanding
42.14 M
69.2 M
N/A
43.47 M
25.61 M
26.73 M
137 M
N/A
N/A
115.08 M
Cash Flow From Operations
(85.28 M)
10.53 M
N/A
(12.78 M)
73.88 M
1.67 M
(89.96 M)
N/A
N/A
(229.86 M)
Total Debt
N/A
477 K
N/A
21.63 M
70.63 M
61.58 M
7.81 M
N/A
N/A
61.11 M
Return On Equity
-8.33
-58.57
N/A
-4.15
11.09
-0.37
-36.31
N/A
N/A
-0.43
Z Score
N/A
N/A
N/A
28.2
6.6
7.2
N/A
N/A
N/A
28.2
Return On Asset
-8.59
-2.5
N/A
-2.79
6.41
-0.03
-21.2
N/A
N/A
-0.16
Book Value Per Share
7.96
2.6
N/A
9.42
18.39
13.99
2.09
N/A
N/A
2.87
Total Asset
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
824.44 M
Debt To Equity
N/A
0.2
N/A
0.052
0.15
0.17
0.029
N/A
N/A
9.4
Last Dividend Paid
N/A
N/A
N/A
N/A
2.0
0.3
N/A
N/A
N/A
N/A
Market Capitalization
752.21 M
741.16 M
538.08 M
1.02 B
792.69 M
761.86 M
1.77 B
N/A
N/A
2.88 B
Price To Earning
N/A
N/A
N/A
N/A
15.25
53.88
N/A
N/A
N/A
N/A
Price To Sales
3.65
12.01
N/A
10.06
3.06
4.87
N/A
N/A
N/A
221.58
Net Income
(30.32 M)
(146.88 M)
N/A
(11.21 M)
51.55 M
(58 K)
(113.77 M)
N/A
N/A
(458.6 M)
Earnings Per Share
-0.72
-2.14
N/A
-0.33
2.03
0.53
-0.91
N/A
N/A
-3.73
Shares Owned By Insiders
N/A
N/A
N/A
N/A
47.69
N/A
N/A
N/A
N/A
66.92
Revenue
206.33 M
61.72 M
N/A
101.35 M
258.98 M
156.3 M
N/A
N/A
N/A
6.94 M
Cash And Equivalents
80 M
100.1 M
N/A
297.48 M
263.13 M
145.91 M
72.83 M
N/A
N/A
380.81 M
Cash Per Share
1.9
1.45
N/A
6.84
10.27
5.46
0.58
N/A
N/A
4.57
Gross Profit
159 M
N/A
N/A
44.29 M
130.29 M
N/A
N/A
N/A
N/A
2.97 M
Day Typical Price
16.25
7.99
12.02
9.56
30.18
26.0
5.74
18.65
8.42
24.13
Accumulation Distribution
75146.85
32436.49
0.0165
N/A
391.38
N/A
3053.2
1125.98
N/A
184.33
Market Facilitation Index
0.0
0.0
0.2
N/A
0.0
N/A
0.0
0.0
N/A
0.0
Daily Balance Of Power
0.2063
0.527
(0.50)
0
(0.43)
9.2 T
(0.14)
0.8889
9.2 T
(1.00)
Period Momentum Indicator
0.65
0.39
(0.10)
(0.38)
(0.15)
1.0
(0.04)
0.4
0.32
(0.40)
Rate Of Daily Change
1.04
1.05
0.99
0.96
1.0
1.04
0.99
1.02
1.04
0.98
Day Median Price
16.58
7.94
12.0
9.56
30.13
26.0
5.71
18.58
8.42
24.2
Price Action Indicator
(0.65)
0.35
N/A
(0.19)
0.1
0.5
0.07
0.43
0.16
(0.40)
Relative Strength Index
59.51
N/A
56.34
N/A
43.22
N/A
N/A
N/A
N/A
40.42
Coefficient Of Variation
1306.93
967.33
(2,801)
(913.55)
(1,257)
517.04
(20,223)
(1,913)
2750.01
(903.14)
Mean Deviation
2.16
1.23
0.7468
1.44
0.9333
2.53
1.98
1.72
1.33
1.28
Jensen Alpha
0.2826
0.1869
(0.08)
(0.26)
(0.1)
0.6748
(0.01)
(0.14)
0.0418
(0.19)
Total Risk Alpha
(0.15)
(0.05)
(0.26)
(0.46)
(0.26)
0.213
(0.36)
(0.47)
(0.18)
(0.47)
Sortino Ratio
0.0418
0.053
N/A
N/A
N/A
0.1786
N/A
N/A
(0.02)
N/A
Downside Variance
6.66
2.28
N/A
N/A
N/A
9.43
N/A
N/A
4.75
N/A
Standard Deviation
2.77
1.78
1.53
1.91
1.21
3.37
2.62
2.58
1.92
1.94
Kurtosis
0.6329
1.33
28.58
(0.20)
(0.08)
1.25
0.3135
2.87
0.4731
2.21
Potential Upside
4.44
4.07
0.9132
3.43
2.14
6.97
5.08
4.63
3.95
2.3
Treynor Ratio
(0.24)
(1.27)
(0.38)
(0.46)
1.53
(1.88)
0.2209
2.15
0.313
0.5854
Maximum Drawdown
12.49
7.7
10.6
7.09
5.46
14.96
11.56
13.34
8.68
10.16
Variance
7.68
3.17
2.33
3.66
1.45
11.39
6.86
6.67
3.67
3.78
Market Risk Adjusted Performance
(0.23)
(1.26)
(0.37)
(0.45)
1.54
(1.87)
0.2309
2.16
0.323
0.5954
Risk Adjusted Performance
0.0638
0.0822
(0.02)
(0.07)
(0.05)
0.1506
0.0035
(0.03)
0.033
(0.08)
Skewness
0.6349
0.7587
4.37
0.113
0.1442
0.7798
0.2653
0.8561
0.1939
(0.16)
Semi Deviation
2.28
1.18
N/A
N/A
N/A
2.12
N/A
N/A
1.49
N/A
Information Ratio
0.039
0.045
(0.10)
(0.16)
(0.17)
0.1626
(0.04)
(0.09)
(0.02)
(0.16)
Value At Risk
(3.62)
(2.74)
(1.33)
(3.82)
(1.75)
(4.31)
(4.69)
(4.65)
(3.57)
(4.15)
Expected Short fall
(2.52)
(1.81)
N/A
N/A
N/A
(3.38)
N/A
N/A
(2.30)
N/A
Downside Deviation
2.58
1.51
N/A
N/A
N/A
3.07
N/A
N/A
2.18
N/A
Semi Variance
5.19
1.4
N/A
N/A
N/A
4.5
N/A
N/A
2.21
N/A

4170 Competition Performance Charts

Five steps to successful analysis of 4170 Competition

4170's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by 4170 in relation to its competition. 4170's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of 4170 in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact 4170's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to 4170, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your 4170 position

In addition to having 4170 in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Insurance Providers Thematic Idea Now

Insurance Providers
Insurance Providers Theme
Companies providing all types of insurance and insurance services. The Insurance Providers theme has 31 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Insurance Providers Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for 4170 Stock Analysis

When running 4170's price analysis, check to measure 4170's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4170 is operating at the current time. Most of 4170's value examination focuses on studying past and present price action to predict the probability of 4170's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4170's price. Additionally, you may evaluate how the addition of 4170 to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY